FDA Inspection 937313 — Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site)

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site) — FEI 3010625707

The FDA completed an inspection of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site) on May 12, 2015 in Nanjing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 12, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Nanjing (China)